QYResearch Reviewed: The global market of anticoagulants growth rate is at 6.03% from 2012 to 2016

QYResearch Reviewed: The global market of anticoagulants growth rate is at 6.03% from 2012 to 2016 www.qyresearch.com

QYResearch Beijing Hengzhou Bozhi International Information Consulting

Web: qyresearchglobal.com | qyresearcheurope.com | qyresearch.com | qyresearch.com/english | qyresearchjapan.com TEL:+86-13660489419, Office:+86-2086655165 Media: press@qyresearch.com Marketing: sales@qyresearch.com Facebook: @QYResearchOfficial Twitter: @QYResearch_ Wechat Official Account: QYResearch, Weibo: 恒州博智 www.qyresearch.com

QYResearch Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

www.qyresearch.com

QYResearch According to QYResearch, In the last several years, global market of anticoagulants developed rapidly. In 2016, global revenue of anticoagulants is nearly 20000 M USD. And the global growth rate is at 6.03% from 2012 to 2016.

The classification of anticoagulants includes PAI, LMWH, DTI, DFXa, VKA, and Other, and the proportion of PAI in 2016 is about 31.07%, and the proportion is in decreasing quickly from 2012 to 2016. The market for DFXa, is growth quickly in past five years the market share increase from 7.45% in 2016 to 26.67% in 2016.

Anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of anticoagulants used to treat AF, and the revenue in 2016 is 13118 M USD.

www.qyresearch.com

QYResearch Europe region is the largest supplier of anticoagulants, with a production market share nearly 56.40% in 2016. North America is the second largest supplier of anticoagulants, enjoying production market share nearly 26.35% in 2016.

North America is the largest consumption place, with a consumption market share nearly 39.72% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 26.83%.

www.qyresearch.com

QYResearch Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche), Boehringer Ingelheim etc. are the leaders of the industry, and they hold key technologies and patents, with highend customers; have been formed in the monopoly position in the industry.

More: http://www.qyresearchglobal.com/goods-1212867.html

www.qyresearch.com